Canterbury DHB

Context

Late Effects Screening after Allogeneic Transplant

For details of late effects follow-up refer to the National Marrow Donor Program guidelines for physicians or download the app for Android or iOS.

The Anthony Nolan Trust also produces information for GPs on late effects follow-up.

In This Section

Late follow-up of transplant survivors - summary for referring physicians and GPs

Long term Complications and Follow-up

Cancer Screening in HCT Survivors

Vaccination Prophylaxis post-SCT

About this Canterbury DHB document (202919):

Document Owner:

Andrew Butler (see Who's Who)

Issue Date:

December 2016

Next Review:

December 2018

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 202919